177Lu-Pentixather

N/A

Report date: 2025/11/20 11:38:00
NME

Base Information

Drug Name177Lu-Pentixather
Drug Alias Nameradiolabeled pentixather[177Lu]Pentixather177Lu Pentixather[177Lu]Lu-PentixaTher
ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsMultiple MyelomaLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active IndicationsLeukemia
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A